Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.980
-0.190 (-5.99%)
Nov 19, 2026, 4:00 PM EST - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $110.83 million as of November 19, 2026. It is the 23,914th most valuable company in the world and the 3,919th biggest in the United States. Its market cap has decreased by 55.66% in one year.
Market Cap
110.83M
Enterprise Value
344.10M
1-Year Change
-55.66%
Global Rank
Country Rank
#3,919 United States
Category
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $110.83M, an increase of 139.31%. That is a compound annual growth rate of 12.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 110.83M | -51.52% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Codexis | 126.04M |
| MacroGenics | 125.90M |
| ALX Oncology Holdings | 125.41M |
| enGene Therapeutics | 123.98M |
| Adagene | 122.20M |
| NRx Pharmaceuticals | 121.14M |
| Spruce Biosciences | 117.37M |
| Retension Pharmaceuticals | 115.73M |